Oruen-Cardiology is the leading multimedia platform
Committed to improving international communication and medical education for physicians with clinical interests in Cardiology.
Latest News
FDA Drug Approval Decisions Expected in July 2024
The PDUFA date refers to the deadline set by the US Food and Drug Administration for reviewing drug applications. The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug...
FLOW: Semaglutide cuts kidney, cardiovascular, death risks regardless of SGLT2 use
Key takeaways: Semaglutide benefits were observed for adults with type 2 diabetes and chronic kidney disease whether or not they used SGLT2 inhibitors. The FLOW trial was not powered to observe effects for those on SGLT2s. ORLANDO — Semaglutide use was associated with...
Dapagliflozin reduces diuretic doses, daily uptitrations and hospital stay for acute HF
Key takeaways: Dapagliflozin did not improve diuretic efficiency for patients hospitalized with acute HF. It did, however, require fewer diuretic doses, fewer daily uptitrations and shorter hospital stay vs. usual care. Despite dapagliflozin not improving diuretic...
Follow Us
Newsletter
Keep up to date with our latest
articles and journals